Development of novel mouse models to study Clec10a/Mgl2 dynamics in the setting of Mycobacterium tuberculosis infection 2258778

Abstract Introduction Macrophage galactose-type lectin (MGL) is an important modulator of inflammation in various disease settings. While humans possess a single MGL molecule (hMGL/CLEC10A), mice have two homologs of the receptor (mMGL1/Clec10a and mMGL2/Mgl2) that may have overlapping functions with hMGL. We have previously demonstrated that mMGL1 plays an important role in the immune response to Mycobacterium tuberculosis (Mtb) infection by limiting inflammation and augmenting antibacterial activity of macrophages. In contrast, the effects of mMGL2 or mMGL1/2 deficiency have yet to be investigated due to the lack of available knockout mouse models. Methods To address this gap, we generated novel mouse lines that lack mMGL2 alone or in combination with mMGL1 via CRISPR-Cas9 mediated disruption of Mgl2 on the B6.129-Clec10atm1Hed/J background. In vitro assessment was performed in bone marrow derived macrophages (BMDM) from WT, mMGL1 KO, mMGL2 KO, and mMGL1/2 KO mice. Additionally, male and female WT, mMGL2, and mMGL1/2 mice were infected with 400 CFU Mtb via aerosol, and microbiological, immunological, and histological outcomes were assessed 8 weeks post-infection. Results Our in vitro killing assay confirmed that while mMGL1 KO macrophages exhibit significantly higher Mtb burden compared to WT, there was only a modest increase in bacterial burden in mMGL2 KO BMDM and no difference between WT and mMGL1/2 BMDM. In contrast, our preliminary in vivo study showed no difference in lung bacterial burden between WT and mMGL2 KO and significantly reduced bacterial burden in mMGL1/2 KO mice. Interestingly, assessment of lung cytokine levels revealed that mMGL2 KO mice exhibit more pro-inflammatory cytokine production (e.g., IL-1β) than WT counterparts. In comparison, mMGL1/2 KO mice had generally similar or depressed cytokines compared to WT, consistent with microbiological outcomes. Conclusion These results highlight the functional divergence of mMGL1 and mMGL2 in the murine immune response to Mtb. Funding Source NIH/NHLBI R01HL181469 Topic Categories Microbial, Parasitic, and Fungal Immunology (MPF)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.624
Primary Topic
Inflammation biomarkers and pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of novel mouse models to study Clec10a/Mgl2 dynamics in the setting of Mycobacterium tuberculosis infection 2258778

Mark Endsley, Janice Endsley, Maki Wakamiya, Reina Paez
The Journal of Immunology
Inflammation biomarkers and pathways
article

Development of novel mouse models to study Clec10a/Mgl2 dynamics in the setting of Mycobacterium tuberculosis infection 2258778

Mark Endsley, Janice Endsley, Maki Wakamiya, Reina Paez
article en

Abstract

Abstract Introduction Macrophage galactose-type lectin (MGL) is an important modulator of inflammation in various disease settings. While humans possess a single MGL molecule (hMGL/CLEC10A), mice have two homologs of the receptor (mMGL1/Clec10a and mMGL2/Mgl2) that may have overlapping functions with hMGL. We have previously demonstrated that mMGL1 plays an important role in the immune response to Mycobacterium tuberculosis (Mtb) infection by limiting inflammation and augmenting antibacterial activity of macrophages. In contrast, the effects of mMGL2 or mMGL1/2 deficiency have yet to be investigated due to the lack of available knockout mouse models. Methods To address this gap, we generated novel mouse lines that lack mMGL2 alone or in combination with mMGL1 via CRISPR-Cas9 mediated disruption of Mgl2 on the B6.129-Clec10atm1Hed/J background. In vitro assessment was performed in bone marrow derived macrophages (BMDM) from WT, mMGL1 KO, mMGL2 KO, and mMGL1/2 KO mice. Additionally, male and female WT, mMGL2, and mMGL1/2 mice were infected with 400 CFU Mtb via aerosol, and microbiological, immunological, and histological outcomes were assessed 8 weeks post-infection. Results Our in vitro killing assay confirmed that while mMGL1 KO macrophages exhibit significantly higher Mtb burden compared to WT, there was only a modest increase in bacterial burden in mMGL2 KO BMDM and no difference between WT and mMGL1/2 BMDM. In contrast, our preliminary in vivo study showed no difference in lung bacterial burden between WT and mMGL2 KO and significantly reduced bacterial burden in mMGL1/2 KO mice. Interestingly, assessment of lung cytokine levels revealed that mMGL2 KO mice exhibit more pro-inflammatory cytokine production (e.g., IL-1β) than WT counterparts. In comparison, mMGL1/2 KO mice had generally similar or depressed cytokines compared to WT, consistent with microbiological outcomes. Conclusion These results highlight the functional divergence of mMGL1 and mMGL2 in the murine immune response to Mtb. Funding Source NIH/NHLBI R01HL181469 Topic Categories Microbial, Parasitic, and Fungal Immunology (MPF)

The Journal of ImmunologyVol. 215(Supplement_1)
The University of Texas Medical Branch at Galveston (US)
Good health and well-being
Openalex Percentile: Top 15%
Inflammation biomarkers and pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.